Key result
High expression of ANGPTL4 in cervical cancer patients was an independent predictor of poor overall survival compared to low expression.
Why the study?
The expression status and prognostic role of angiopoietin-like protein 4 (ANGPTL4) in cervical cancer remained unclear.
Does high ANGPTL4 expression predict poor overall and disease-free survival in patients with cervical cancer?
Cohort (n=160)
No
Does high ANGPTL4 expression predict poor overall and disease-free survival in patients with cervical cancer?
Upregulated ANGPTL4 expression is an independent predictor of poor overall and disease-free survival in patients with cervical cancer.
Answers are grounded in this paper and cite their sources.
ANGPTL4 expression may aid cervical cancer prognostication; leaves open prospective validation before clinical use.
Background: Angiopoietin-like protein 4 (ANGPTL4) has been demonstrated highly expressed in some cancers, but it also was downregulated in others through DNA methylation. However, the expression status of ANGPTL4 in cancer of cervix remains unclear. Thus, our present study attempts to investigate the role of ANGPTL4 in the prognosis of patients with cervical cancer. Methods: Immunohistochemistry, western blotting and qRT-PCR were performed to investigate the expressive level of ANPGTL4 in cervical cancer tissues and paired noncancer tissues. The relationship of ANGPTL4 expression and clinicopathological factors was measured by Chi-square test. Overall and disease-free survival (OS and DFS) rates were estimated and compared by using Kaplan-Meier method and log-rank test, respectively. To assess the prognostic significance of ANGPTL4 in cervical cancer patients, the Cox regression model was utilized to process univariate and multivariate analyses. Results: ANGPTL4 was upregulated in cervical cancer samples and advanced tumor stage, deep stromal invasion, lymph node metastasis, lymphovascular space invasion, as well as poor OS and DFS were shown to be tightly correlated with it. Results of Cox multivariate analysis demonstrated that ANGPTL4 expression was an independent prognostic factor for OS and DFS in cervical cancer. Conclusion: Upregulated ANGPTL4 seems to be a useful marker for poor prognosis in cervical cancer.
No takes yet. Share an insight, caveat, or question.
Nie et al. (2019) conducted a cohort in Cervical cancer (n=160). High ANGPTL4 expression vs. Low ANGPTL4 expression was evaluated on Overall survival (OS) (HR 2.191, 95% CI 1.046-4.592, p=0.038). High expression of ANGPTL4 in cervical cancer patients was an independent predictor of poor overall survival compared to low expression.
Synapse has enriched 10 related papers. Consider them for comparative context: